BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33116851)

  • 21. Recurrent epimutation of SDHC in gastrointestinal stromal tumors.
    Killian JK; Miettinen M; Walker RL; Wang Y; Zhu YJ; Waterfall JJ; Noyes N; Retnakumar P; Yang Z; Smith WI; Killian MS; Lau CC; Pineda M; Walling J; Stevenson H; Smith C; Wang Z; Lasota J; Kim SY; Boikos SA; Helman LJ; Meltzer PS
    Sci Transl Med; 2014 Dec; 6(268):268ra177. PubMed ID: 25540324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.
    Doyle LA; Nelson D; Heinrich MC; Corless CL; Hornick JL
    Histopathology; 2012 Nov; 61(5):801-9. PubMed ID: 22804613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs.
    Flavahan WA; Drier Y; Johnstone SE; Hemming ML; Tarjan DR; Hegazi E; Shareef SJ; Javed NM; Raut CP; Eschle BK; Gokhale PC; Hornick JL; Sicinska ET; Demetri GD; Bernstein BE
    Nature; 2019 Nov; 575(7781):229-233. PubMed ID: 31666694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
    Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.
    Beadling C; Patterson J; Justusson E; Nelson D; Pantaleo MA; Hornick JL; Chacón M; Corless CL; Heinrich MC
    Cancer Med; 2013 Feb; 2(1):21-31. PubMed ID: 24133624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization and pathogenesis of gastrointestinal stromal tumor.
    Niinuma T; Suzuki H; Sugai T
    Transl Gastroenterol Hepatol; 2018; 3():2. PubMed ID: 29441367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour.
    Schaefer IM; Ströbel P; Cameron S; Beham A; Otto C; Schildhaus HU; Agaimy A
    Histopathology; 2014 Feb; 64(3):421-30. PubMed ID: 24266839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
    Papke DJ; Forgó E; Charville GW; Hornick JL
    Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
    Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma.
    Ohno T; Hiraga J; Ohashi H; Sugisaki C; Li E; Asano H; Ito T; Nagai H; Yamashita Y; Mori N; Kinoshita T; Naoe T
    Int J Hematol; 2006 May; 83(4):341-7. PubMed ID: 16757436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status.
    Kakkar A; Kumar A; Jha P; Goyal N; Mallick S; Sharma MC; Suri A; Singh M; Kale SS; Julka PK; Sarkar C; Suri V
    Neuropathology; 2014 Aug; 34(4):333-42. PubMed ID: 24521400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
    Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
    Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.
    Belinsky MG; Rink L; von Mehren M
    Front Oncol; 2013; 3():117. PubMed ID: 23730622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
    Lalezari S; Chou AP; Tran A; Solis OE; Khanlou N; Chen W; Li S; Carrillo JA; Chowdhury R; Selfridge J; Sanchez DE; Wilson RW; Zurayk M; Lalezari J; Lou JJ; Ormiston L; Ancheta K; Hanna R; Miller P; Piccioni D; Ellingson BM; Buchanan C; Mischel PS; Nghiemphu PL; Green R; Wang HJ; Pope WB; Liau LM; Elashoff RM; Cloughesy TF; Yong WH; Lai A
    Neuro Oncol; 2013 Mar; 15(3):370-81. PubMed ID: 23328811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal Tumors.
    Indio V; Schipani A; Nannini M; Urbini M; Rizzo A; De Leo A; Altimari A; Di Scioscio V; Messelodi D; Tarantino G; Astolfi A; Pantaleo MA
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33806389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
    Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
    Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
    Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.